Q1: How strong is the clinical evidence for the P-Shot®? The evidence base for the P-Shot® varies meaningfully by indication, and Dr. Ortiz is transparent about this at every consultation. For Peyronie's disease, the 2025 clinical literature is most supportive — multiple studies including a 72-patient prospective trial and a 36-patient cohort study demonstrated reductions in penile curvature and plaque thickness with a favorable safety profile. For erectile dysfunction, a 2023 systematic review of seven studies showed improvement in sexual function among PRP-treated men, and an RCT demonstrated IIEF-5 improvements versus placebo — but current European urology guidelines still classify PRP as experimental for ED, and Dr. Ortiz presents it as a promising regenerative option within a comprehensive protocol rather than a standalone proven ED treatment. Patients deserve accurate information to make informed decisions — not overclaiming.

Q2: How is the P-Shot® different from Viagra or Cialis? PDE5 inhibitors like Viagra and Cialis work by increasing blood flow to the penis at the time of sexual activity — they require you to take them in anticipation of intercourse and do not change the underlying tissue health of the penis over time. The P-Shot® works differently: it stimulates angiogenesis and tissue regeneration in the penile vasculature and nerve structures — addressing the biological substrate of erectile function rather than compensating for it temporarily. For men who respond well to PDE5 inhibitors, the P-Shot® is not necessarily an alternative but can be a complement — addressing the underlying tissue while medication handles the acute need. For men who don't respond to or cannot take PDE5 inhibitors, the P-Shot® addresses a mechanism those medications cannot reach. Dr. Ortiz evaluates which role PRP plays in your specific picture at consultation.

Q3: Is the P-Shot® appropriate for Peyronie's disease? Yes — and this is the indication where Dr. Ortiz is most confident in the clinical rationale for PRP. Peyronie's disease involves fibrotic plaque formation in the tunica albuginea; PRP's anti-fibrotic properties and collagen remodeling effects directly target this pathology. The 2025 clinical literature includes a 36-patient cohort study demonstrating significant reductions in curvature and plaque thickness after three weekly PRP injections, and a 72-patient study documenting curvature reduction with good tolerability. PRP is most appropriate for men in the stable phase of Peyronie's (curvature consistent for at least 6 months) as part of a structured intervention plan. Dr. Ortiz evaluates whether you are in the active or stable phase, the degree of curvature, and whether PRP is appropriate as a standalone or combined approach.

Q4: Can the P-Shot® be combined with testosterone therapy or Alma Duo? Yes — and for most men, the best outcomes come from addressing the penile tissue alongside the systemic factors driving sexual dysfunction. If testosterone deficiency is contributing to ED or Peyronie's, optimizing testosterone alongside the P-Shot® addresses both the hormonal and the tissue dimensions simultaneously. The Alma Duo for Men — low-intensity acoustic wave therapy available at DNA Wellness — works through a complementary mechanism (promoting angiogenesis and tissue remodeling through acoustic energy) and pairs well with the P-Shot® for comprehensive vascular ED management. PT-141 (Bremelanotide), which works through the brain's arousal pathways, addresses the desire component that PRP and Alma Duo do not directly reach. Dr. Ortiz discusses the appropriate multimodal protocol for your specific pattern at consultation.

Q5: Is the P-Shot® available in Bonita Springs and Southwest Florida? Yes. Dr. Katherine Ortiz offers the P-Shot® PRP for Men at DNA Wellness and Longevity Institute, located at 26800 S Tamiami Trail, Suite 380 in Bonita Springs. All consultations and procedures are conducted with complete confidentiality. The clinic serves patients throughout Bonita Springs, Naples, Estero, Fort Myers, and surrounding Southwest Florida communities. Call (239) 250-7930 to schedule your private consultation.